Biomechanical Mechanisms Underlying Pathologic Hepatic Stellate Cell Behavior in Liver Fibrosis
肝纤维化中肝星状细胞病理行为的生物力学机制
基本信息
- 批准号:10538260
- 负责人:
- 金额:$ 4.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAffectAscitesAutoimmuneAutoimmune DiseasesAutomobile DrivingBehaviorBiochemicalBiocompatible MaterialsBiomechanicsBiomimeticsCell Differentiation processCellsCessation of lifeCharacteristicsChemistryCirrhosisClinicalCuesCytokine SignalingDiseaseDoseEncephalopathiesEnvironmentEtiologyExhibitsExposure toExtracellular MatrixExtrahepaticFibrosisGenotypeGoalsHepatic Stellate CellHepatitis B TherapyHepatitis CHospitalsHybridsHydrogelsIn VitroInjuryInstructionKnowledgeLightLiteratureLiverLiver FibrosisLiver diseasesLiver parenchymaLocationMalignant NeoplasmsMechanicsMediator of activation proteinMemoryMetabolic DiseasesMolecularNatureNuclear TranslocationPathogenesisPathologicPathologic ProcessesPathologyPatientsPhenotypePortal HypertensionPredispositionPrimary carcinoma of the liver cellsProcessPropertyRelaxationResearchRiskRoleSideSignal TransductionStressStructure-Activity RelationshipSystemTherapeutic InterventionTimeTissuesTraining ActivityUniversitiesVirus DiseasesVisible Radiationantifibrotic treatmentbasebiomarker signatureburden of illnesscell behaviorchronic liver diseasecurative treatmentsethylene glycolexperiencefibrogenesisin vivoinsightinterestmechanical propertiesmechanical signalmechanotransductionmigrationnonalcoholic steatohepatitisnovelpatient populationresponsesimulationspatiotemporalstellate celltargeted treatmenttherapeutic developmenttransdifferentiationwound healing
项目摘要
PROJECT SUMMARY
The unregulated activation of hepatic stellate cells is a key step in the pathogenesis of liver fibrosis, a condition
which arises from multiple etiologies including viral infections, autoimmune diseases, metabolic disorders, and
toxic insults. When activated, stellate cells become myofibroblastic and adopt wound healing functions. Cirrhosis,
the most advanced stage of fibrosis, is associated with severe extrahepatic complications and a lifetime
increased risk for hepatocellular carcinoma. Fibrosis was once thought to be a unidirectional, irreversible
condition, but recent advances in curative treatment for hepatitis B and C have demonstrated that fibrosis is able
to regress. Therefore, effective antifibrotic therapies are in high demand to treat all stages of fibrosis from any
etiology. A promising approach is to inhibit the many functions of the activated stellate cell, or the activation
process itself, since these steps are central to driving disease pathogenesis.
Like all cells, activated stellate cells respond to cues delivered by their surrounding extracellular matrix (ECM).
Some of these cues are biochemical in nature. However, the mechanical properties of the ECM are also
instructive and provide signals that have profound effects on cell differentiation, migration, remodeling, and tissue
organization. The liver possesses two mechanical properties of notable interest: stiffness, the extent to which an
object resists deformation to an applied force, and stress relaxation, the ability to dissipate energy from an
applied force. An understanding of how stiffness and stress relaxation act independently and synergistically to
affect activated hepatic stellate cells may reveal previously unexplored opportunities for therapeutic
development. The objectives of the proposed research are therefore to modulate the behavior of hepatic stellate
cells by tuning matrix mechanical properties in a spatiotemporally precise manner. We have developed
photoresponsive poly(ethylene glycol)/liver ECM hybrid hydrogels with tunable stress relaxation that can be
reversibly stiffened with visible light. The Specific Aims of the proposed research are to (1) elucidate the
independent role of stress relaxation on hepatic stellate cell mechanical memory and (2) assess hepatic stellate
cell durotactic migratory capacity as a function of stress relaxation. In addition to functional readouts of healthy
and diseased cell phenotypes, we will use established metrics for cellular mechanosensing, such as YAP nuclear
translocation, to develop clear structure-function relationships between ECM mechanics, mechanosensing, and
cell behavior. The anticipated product of this research is a causal understanding of the response of stellate cells
to mechanical signals. This research will be a collaborative effort between Northwestern University’s Department
of Chemistry, Northwestern Memorial Hospital, and external collaborators. In carrying out the proposed Aims
and associated training activities, I will develop a unique skillset that allows me to address biomedical problems
using materials chemistry as a means of accelerating translational scientific discovery.
项目概要
肝星状细胞的不受调节的激活是肝纤维化发病机制的关键步骤,肝纤维化是一种疾病
由多种病因引起,包括病毒感染、自身免疫性疾病、代谢紊乱和
当被激活时,星状细胞变成肌纤维细胞并具有伤口愈合功能。
纤维化的最晚期阶段,与严重的肝外并发症和终生相关
肝细胞癌的风险增加曾经被认为是单向的、不可逆转的。
但乙型和丙型肝炎治疗的最新进展表明,纤维化能够
因此,迫切需要有效的抗纤维化疗法来治疗任何阶段的纤维化。
一种有前途的方法是抑制激活的星状细胞的许多功能,或激活。
过程本身,因为这些步骤是驱动疾病发病机制的核心。
与所有细胞一样,激活的星状细胞对其周围细胞外基质 (ECM) 传递的信号做出反应。
其中一些线索本质上是生物化学的,但是 ECM 的机械特性也是如此。
具有指导性并提供对细胞分化、迁移、重塑和组织产生深远影响的信号
肝脏具有两个值得注意的机械特性:僵硬程度,即僵硬程度。
物体抵抗所施加的力的变形,以及应力松弛,即耗散来自物体的能量的能力
了解刚度和应力松弛如何独立和协同作用。
影响活化的肝星状细胞可能揭示以前未探索的治疗机会
因此,拟议研究的目标是调节肝星状细胞的行为。
我们开发了通过以时空精确的方式调整基质机械特性来调节细胞的方法。
具有可调应力松弛功能的光响应聚乙二醇/肝脏 ECM 混合水凝胶
所提出的研究的具体目标是(1)阐明。
应力松弛对肝星状细胞机械记忆的独立作用和(2)评估肝星状细胞
除了健康的功能读数之外,细胞杜罗定向迁移能力作为压力松弛的函数。
和患病细胞表型,我们将使用细胞机械传感的既定指标,例如 YAP 核
易位,以在 ECM 力学、机械传感和
这项研究的预期成果是对星状细胞反应的因果理解。
这项研究将是西北大学系之间的合作成果。
西北纪念医院化学系和外部合作者在实现拟议目标时。
和相关的培训活动,我将发展一套独特的技能,使我能够解决生物医学问题
使用材料化学作为加速转化科学发现的手段。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vivian Zhang其他文献
Vivian Zhang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vivian Zhang', 18)}}的其他基金
Biomechanical Mechanisms Underlying Pathologic Hepatic Stellate Cell Behavior in Liver Fibrosis
肝纤维化中肝星状细胞病理行为的生物力学机制
- 批准号:
10656257 - 财政年份:2022
- 资助金额:
$ 4.23万 - 项目类别:
相似国自然基金
探索间质机械力通过影响SMAD4/JNK/PIN1功能轴对胰腺癌糖代谢重编程的调控机制
- 批准号:82372906
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
色氨酸代谢产物5-HIAA通过干预AHR-NFATc1途径影响RA骨破坏的机制研究
- 批准号:82302049
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠道菌群通过短链脂肪酸代谢影响妊娠期糖尿病发病风险的分子流行病学研究
- 批准号:82304218
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SUV39H2通过铁死亡影响乳腺癌转移的作用及机制研究
- 批准号:82303121
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肠罗斯拜瑞氏菌通过丙酸失活酪氨酸激酶JAK2影响STAT3磷酸化阻抑UC肠道纤维化的分子机制研究
- 批准号:82370539
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 4.23万 - 项目类别:
Examining the effects of Global Budget Revenue Program on the Costs and Quality of Care Provided to Cancer Patients Undergoing Chemotherapy
检查全球预算收入计划对接受化疗的癌症患者提供的护理成本和质量的影响
- 批准号:
10734831 - 财政年份:2023
- 资助金额:
$ 4.23万 - 项目类别:
Investigating the role of myenteric macrophages in enteric synucleinopathy
研究肌间巨噬细胞在肠突触核蛋白病中的作用
- 批准号:
10678094 - 财政年份:2023
- 资助金额:
$ 4.23万 - 项目类别:
Crosstalk Between Nurr1 and Risk Factors of Parkinson's Disease and its Regulation by Nurr1's Ligands
Nurr1与帕金森病危险因素的串扰及其配体的调控
- 批准号:
10677221 - 财政年份:2023
- 资助金额:
$ 4.23万 - 项目类别:
Single cell transcriptomics of nerves that lack Remak bundles
缺乏 Remak 束的神经的单细胞转录组学
- 批准号:
10649087 - 财政年份:2023
- 资助金额:
$ 4.23万 - 项目类别: